Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhongyuan Union Stem Cell Bioengineering Co to issue new shares for equity shares acquisition and fund raising


Sunday, 23 Feb 2014 07:00pm EST 

Zhongyuan Union Stem Cell Bioengineering Co:Says to pay 44.54 million yuan and to issue 17,026,857 shares to Wang Hui to acquire a 57.71 pct stake in Shanghai Zhicheng Biological Technology Co Ltd (target company).Says to pay 29.64 million yuan and to issue 2,822,857 shares to a Shanghai-based investment management company to acquire a 12.35 pct stake in target company.Says to pay 20.38 million yuan and to issue 1,941,257 shares to Wang Rong to acquire a 8.49 pct stake in target company.Says to pay 40 million yuan to a Shanghai-based investment partnership to acquire a 5.00 pct stake in target company.Says to pay 38 million yuan to Han Yongqiang to acquire a 4.75 pct stake in target company.Says to pay 11.19 million yuan and to issue 1,066,171 shares to Yu Jiaming to acquire a 4.66 pct stake in target company.Says to pay 30.40 million yuan to another Shanghai-based investment partnership to acquire a 3.80 pct stake in target company.Says to pay 18.24 million yuan to Chen Caizhao to acquire a 2.28 pct stake in target company.Says to pay 7.60 million yuan to Li Henan to acquire a 0.95 pct stake in target company.Issue price at 24.50 yuan per share.Says to issue new shares to raise 266 million yuan for cash payment and working capital.